Galimedix Therapeutics Initiates Phase 2 Study for GAL-101
23 Dec 2024 //
GLOBENEWSWIRE
Galimedix presents new scientific data showing promising effects of GAL-201
08 Mar 2024 //
GLOBENEWSWIRE
Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations
25 Oct 2023 //
ACCESSWIRE
Galimedix Names Luciana Summo Vice President, R&D Operations
25 Oct 2023 //
CONTRACT PHARMA
Théa Open Innovation and Galimedix announce strategic partnership
29 Mar 2023 //
GLOBENEWSWIRE